US 12,109,331 B2
Medical device, and method for manufacturing medical device
Takashi Magara, Nishitokyo (JP)
Assigned to OLYMPUS CORPORATION, Tokyo (JP)
Filed by OLYMPUS CORPORATION, Hachioji (JP)
Filed on Sep. 7, 2021, as Appl. No. 17/467,637.
Application 17/467,637 is a continuation of application No. PCT/JP2020/008921, filed on Mar. 3, 2020.
Claims priority of application No. 2019-042807 (JP), filed on Mar. 8, 2019.
Prior Publication US 2021/0402067 A1, Dec. 30, 2021
Int. Cl. A61L 29/04 (2006.01); A61B 1/005 (2006.01); A61L 29/16 (2006.01); C08L 27/18 (2006.01); C08L 27/20 (2006.01); C08L 63/00 (2006.01)
CPC A61L 29/16 (2013.01) [A61B 1/005 (2013.01); A61L 29/049 (2013.01); A61L 2420/02 (2013.01); C08L 27/18 (2013.01); C08L 27/20 (2013.01); C08L 63/00 (2013.01)] 9 Claims
OG exemplary drawing
 
1. A medical device, comprising:
a resin base including one or more than one material selected from the group consisting of an ethylene propylene resin containing fluorine, a styrene resin containing fluorine, an olefin resin containing fluorine, a vinyl chloride resin containing fluorine, a polyester resin containing fluorine, a polyurethane resin containing fluorine, and a nylon resin containing fluorine;
an underlayer formed on the resin base, the underlayer including an oxazolidone ring; and
an epoxy resin layer formed on the underlayer,
wherein at least one of the resin base and the underlayer comprises a substance having an unsaturated bond of carbon atoms, and the resin base and the underlayer are composited in a three-dimensional uneven structure.